W. Harel
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
Papers in
- Immunology 15
- Immunotherapy and Immune Responses 15
- T-cell and B-cell Immunology 2
- Oncology 8
- CAR-T cell therapy research 7
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- Raymond A. KempfM S MitchellJune Kan‐MitchellHungyi ShauStuart E. LindWilliam D. BoswellSusan GroshenGrace E. Dean
- Journals
- Journal of Clinical Oncology (5 papers)Cancer Immunology Immunotherapy (3 papers)Vox Sanguinis (2 papers)Melanoma Research (1 paper)Transfusion (1 paper)
- Partner nations
- United StatesIsraelUnited Kingdom
In The Last Decade
W. Harel
20 papers receiving 893 citations
Peers
Comparison fields: 5 of 66
- Immunology 738
- Oncology 480
- Hematology 64
- Biotechnology 45
- Radiology, Nuclear Medicine and Imaging 112
Countries citing papers authored by W. Harel
This map shows the geographic impact of W. Harel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Harel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Harel more than expected).
Fields of papers citing papers by W. Harel
This network shows the impact of papers produced by W. Harel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Harel. The network helps show where W. Harel may publish in the future.
Co-authors
The 25 scholars most cited alongside W. Harel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 12 | |
| 2 | 2001 | 2 | |
| 3 | 1998 | 42 | |
| 4 | 1998 | 5 | |
| 5 | 1994 | 39 | |
| 6 | 1993 | 79 | |
| 7 | 1993 | 14 | |
| 8 | 1993 | 32 | |
| 9 | Protection against experimental cerebral metastases of murine melanoma B16 by active immunization. | 1993 | 15 |
| 10 | 1992 | 65 | |
| 11 | 1991 | 32 | |
| 12 | 1990 | 145 | |
| 13 | Increased lysis of melanoma by in vivo-elicited human lymphokine-activated killer cells after addition of antiganglioside antibodies in vitro. | 1990 | 16 |
| 14 | Low-dose cyclophosphamide and low-dose interleukin-2 for malignant melanoma. | 1989 | 18 |
| 15 | 1988 | 155 | |
| 16 | Active specific immunotherapy for melanoma: phase I trial of allogeneic lysates and a novel adjuvant. | 1988 | 210 |
| 17 | 1988 | 4 | |
| 18 | 1985 | 13 | |
| 19 | 1982 | 24 | |
| 20 | Skin allograft survival in lentil lectin-treated mice and rats. | 1981 | 2 |
About W. Harel
W. Harel is a scholar working on Immunology, Oncology, Internal Medicine, Dermatology and Ophthalmology, having authored 20 papers that have together received 924 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (15 papers), CAR-T cell therapy research (7 papers), Cancer Immunotherapy and Biomarkers (4 papers), vaccines and immunoinformatics approaches (2 papers), Platelet Disorders and Treatments (2 papers), RNA Interference and Gene Delivery (2 papers), T-cell and B-cell Immunology (2 papers) and Acute Myocardial Infarction Research (2 papers). The work is most often cited by research in Immunology (738 citations), Oncology (480 citations), Hematology (64 citations), Biotechnology (45 citations) and Radiology, Nuclear Medicine and Imaging (112 citations). W. Harel has collaborated with scholars based in United States, Israel and United Kingdom. Frequent co-authors include Raymond A. Kempf, M S Mitchell, June Kan‐Mitchell, Hungyi Shau, Stuart E. Lind, William D. Boswell, Susan Groshen, Grace E. Dean, E C Bradley and Malcolm S. Mitchell. Their work appears in journals such as Journal of Clinical Oncology, Cancer Immunology Immunotherapy, Vox Sanguinis, Melanoma Research and Transfusion.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.